Skip to main content

PAPEL FISIOPATOLOGICO DE LA VITAMINA D Y LA MICROBIOTA EN LA HIPERTENSION PULMONAR Y EN LA DISFUNCION ERECTIL

PID2019-107363RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Functional expression of inwardly rectifying and ATP-sensitive potassium channels in human pulmonary artery smooth muscle and endothelial cells.

  • Barreira, Bianca
  • Morales Cano, Daniel
  • Moreno Gutiérrez, Laura
  • de Olaiz, Beatriz
  • Adão, Rui
  • Cogolludo Torralba, Ángel Luis
  • Pérez Vizcaíno, Francisco
  • Sancho González, María
The resting membrane potential (V) of vascular cells is a key determinant of arterial tone, integrating multiple ionic conductances to control smooth muscle contractility and endothelial signalling. In the human pulmonary circulation, the specific K channels responsible for setting the V of smooth muscle cells (SMCs) and endothelial cells (ECs) remain incompletely defined. This study investigated whether inwardly rectifying (Kir2) and ATP-sensitive (K) K channels are functionally expressed in native human pulmonary artery (PA) SMCs and ECs and assessed their contribution to vascular tone. Combining patch-clamp electrophysiology, immunofluorescence and wire myography, we evaluated channel expression and function in freshly isolated PASMCs and PAECs, and intact PAs. Kir2 channels were identified by Ba-sensitive inward currents with a characteristic rectification profile, supported by immunolabelling of Kir2.1 and Kir2.2 subunits. Functionally, BaCl induced concentration-dependent contractions of PA rings and significantly attenuated acetylcholine-evoked, endothelium-dependent relaxation, revealing a tonic vasodilatory role for Kir2 channels. K currents, activated by pinacidil and blocked by glibenclamide and PNU-37883A, were also observed in PASMCs and PAECs, consistent with immunodetection of Kir6.1 and SUR2 subunits. In isolated PAs, pinacidil elicited concentration-dependent vasodilatation, which was significantly reduced by K channel blockade. Collectively, these findings demonstrate for the first time the functional presence of Kir2 and K channels in native human pulmonary vascular cells, and their modulatory role on V and arterial tone. These channels emerge as key electro-metabolic regulators of pulmonary vascular function and promising therapeutic targets in diseases characterized by V dysregulation, such as pulmonary arterial hypertension. KEY POINTS: Inwardly rectifying (Kir2) K channels are key regulators of the resting membrane potential (V) in different vascular cell types across multiple vascular beds, whereas ATP-sensitive (K) K channels detect changes in the metabolic state of vascular cells and translate these changes into V modulation. Despite their well-established physiological relevance, a comprehensive characterization of Kir2 and K channels in freshly isolated human pulmonary vascular cells - particularly within the endothelium - remains lacking. Our study provides compelling evidence for the functional expression of Kir2 and K channels in native human pulmonary arterial smooth muscle and endothelial cells, demonstrating their contribution to V regulation and pulmonary vascular tone at rest and in response to specific stimuli.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Vitamin D as an add-on therapy to phosphodiesterase-5 inhibitor in experimental pulmonary arterial hypertension

  • Adão, Rui
  • Barreira, Bianca
  • Paternoster, Elena
  • Morales-Cano, Daniel
  • Olivencia, Miguel A.
  • Quintana-Villamandos, Begoña
  • Rodríguez Chiaradia, Diego Agustín
  • Cogolludo, Angel
  • Perez-Vizcaino, Francisco
Severe vitamin D (vitD) deficiency is a very common condition in patients with pulmonary arterial hypertension (PAH), and it is a predictor of poor prognosis. There is emerging evidence suggesting a connection between the insufficient response to phosphodiesterase-5 inhibitors (PDE5i) and vitD deficiency in patients with PAH. In the present translational study, vitD deficiency was induced in Wistar rats by exposure to vitD-free diet for 5 wk and followed by Su5416 administration and hypoxia (10%) for 3 wk, a standard experimental model of PAH. Then, rats were randomized to either 1) the PDE5i tadalafil and continuing vitD-free diet or 2) tadalafil plus a single dose of vitD and standard diet for 4 wk. VitD supplementation improved exercise capacity and right ventricular function and decreased systolic right ventricular pressure, right atrial hypertrophy, right ventricular hypertrophy, and pulmonary arterial remodeling. VitD improved the ex vivo endothelium-dependent response to acetylcholine, indicating an improvement in NO bioavailability, which also resulted in an acute ex vivo response to sildenafil. Thus, the restoration of vitD, by rescuing endothelial function and PDE5i effectiveness, significantly improved the histological, hemodynamic, and functional features of rats with PAH. VitD may be especially beneficial for PDE5i-treated patients with PAH. NEW & NOTEWORTHY Severe vitamin D deficiency is very prevalent in patients with pulmonary arterial hypertension. We show that addition of vitamin D to the standard PDE5 inhibitor tadalafil increases its therapeutic efficacy in pulmonary hypertensive rats that were deficient in vitamin D., This study was supported by grants from Ministerio de Economía y Competitividad (PID2019-107363RB-I00 and PID2020-117939RB-I00), Fundación Contra la Hipertensión Pulmonar (FCHP, Empathy study) and Sociedad Española de Neumología y Cirugía Torácica (SEPAR, 1204/2022). R.A. is funded by the EC Horizon 2020 Marie Skłodowska-Curie grant (No. 847635), and acknowledges Fundação para a Ciência e a Technologia (FCT) under the auspices of the project RELAX-2-PAH (2022.08921.PTDC; https://doi.org/10.54499/2022.08921.PTDC). M.A.O. is funded by Universidad Complutense/Banco Santander CT63/19-CT64/19.
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

Novel loss-of-function KCNA5 variants in pulmonary arterial hypertension

  • Vera-Zambrano, Alba
  • Lago Docampo, Mauro
  • Gallego, Natalia
  • Franco-Gonzalez, Juan Felipe
  • Morales-Cano, Daniel
  • Cruz Utrilla, Alejandro
  • Villegas-Esguevillas, Marta
  • Fernández-Malavé, Edgar
  • Escribano Subías, Pilar
  • Tenorio Castaño, Jair Antonio
  • Perez-Vizcaino, Francisco
  • Valverde Pérez, Diana
  • Mourin Gonzalez, Maria Teresa
  • Cogolludo Agustin, Miguel Angel
Reduced expression and/or activity of Kv1.5 channels (encoded by KCNA5) is a common hallmark in human or experimental pulmonary arterial hypertension (PAH). Likewise, genetic variants in KCNA5 have been found in patients with PAH, but their functional consequences and potential impact on the disease are largely unknown. Herein, this study aimed to characterize the functional consequences of seven KCNA5 variants found in a cohort of patients with PAH. Potassium currents were recorded by patch-clamp technique in HEK293 cells transfected with wild-type or mutant Kv1.5 cDNA. Flow cytometry, Western blot, and confocal microscopy techniques were used for measuring protein expression and cell apoptosis in HEK293 and human pulmonary artery smooth muscle cells. KCNA5 variants (namely, Arg184Pro and Gly384Arg) found in patients with PAH resulted in a clear loss of potassium channel function as assessed by electrophysiological and molecular modeling analyses. The Arg184Pro variant also resulted in a pronounced reduction of Kv1.5 expression. Transfection with Arg184Pro or Gly384Arg variants decreased apoptosis of human pulmonary artery smooth muscle cells compared with the wild-type cells, demonstrating that KCNA5 dysfunction in both variants affects cell viability. Thus, in addition to affecting channel activity, both variants were associated with impaired apoptosis, a crucial process linked to the disease. The estimated prevalence of dysfunctional KCNA5 variants in the PAH population analyzed was around 1%. The data indicate that some KCNA5 variants found in patients with PAH have critical consequences for channel function, supporting the idea that KCNA5 pathogenic variants may be a causative or contributing factor for PAH., Comunidad de Madrid | Ref. B2017/BMD-3727, Instituto de Salud Carlos III | Ref. PI18/01233, Instituto de Salud Carlos III | Ref. PI21/01593, Agencia Estatal de Investigación | Ref. PID2020-117939RB-I00, Agencia Estatal de Investigación | Ref. PID2019-104366RB-C21, Agencia Estatal de Investigación | Ref. PID2019-107363RB-I00, Xunta de Galicia | Ref. ED481A-2018/304
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Supplementation with a cocoa–carob blend, alone or in combination with metformin, attenuates diabetic cardiomyopathy, cardiac oxidative stress and inflammation in Zucker diabetic rats

  • García-Díez, Esther
  • López-Oliva, Elvira
  • Caro-Vadillo, Alicia
  • Pérez-Vizcaíno, Francisco
  • Pérez-Jiménez, Jara
  • Ramos, Sonia
  • Martín, M. Ángeles
This article belongs to the Special Issue Oxidative Stress in Metabolic Cardiomyopathy., Diabetic cardiomyopathy (DCM) is one of the main causes of mortality among diabetic patients, with oxidative stress and inflammation major contributors to its development. Dietary flavonoids show strong antioxidant and anti-inflammatory activities, although their potential additive outcomes in combination with antidiabetic drugs have been scarcely explored. The present study investigates the cardioprotective effects of a cocoa–carob blend (CCB) diet, rich in flavonoids, alone or in combination with metformin, in the development of DCM. Zucker diabetic fatty rats (ZDF) were fed with a CCB rich-diet or a control diet, with or without metformin for 12 weeks. Glucose homeostasis, cardiac structure and function, and oxidative and inflammatory biomarkers were analysed. CCB improved glucose homeostasis, and mitigated cardiac dysfunction, hypertrophy, and fibrosis in ZDF rats. Mechanistically, CCB counteracted oxidative stress in diabetic hearts by down-regulating NADPH oxidases, reducing reactive oxygen species (ROS) generation and modulating the sirtuin-1 (SIRT1)/ nuclear factor E2-related factor 2 (Nrf2) signalling pathway, overall improving antioxidant defence. Moreover, CCB suppressed inflammatory and fibrotic reactions by inhibiting nuclear factor kappa B (NFκB) and pro-inflammatory and pro-fibrotic cytokines. Noteworthy, several of these effects were further improved in combination with metformin. Our results demonstrate that CCB strongly prevents the cardiac remodelling and dysfunction observed in diabetic animals, highlighting its potential, alone or in adjuvant therapy, for treating DCM., This work was supported by the grant RTI2018-095059-B-I00 and PID2019-107363RB-I00, funded by MCIN/AEI/10.13039/501100011033/and by “ERDF A way of making Europe”. E.G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020-AI/BIO-18529)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Novel loss of function KCNA5 variants in pulmonary arterial hypertension, Running title: Novel loss of function KCNA5 variants in PAH

  • Vera-Zambrano, Alba
  • Lago-Docampo, Mauro
  • Gallego, Natalia
  • Franco-Gonzalez, Juan Felipe
  • Morales-Cano, Daniel
  • Cruz-Utrilla, Alejandro
  • Villegas-Esguevillas, Marta
  • Fernández-Malavé, Edgar
  • Escribano-Subias, Pilar
  • Tenorio, Jair
  • Pérez-Vizcaíno, Francisco
  • Valverde, Diana
  • González, Teresa
  • SICPH investigators
  • Cogolludo, Angel
12 p.-7 fig., Reduced expression and/or activity of Kv1.5 channels (encoded by KCNA5) is a common hallmark in human or experimental pulmonary arterial hypertension (PAH). Likewise, genetic variants in KCNA5 have been found in PAH patients, but their functional consequences and potential impact on the disease are largely unknown. Herein, we aimed to characterize the functional consequences of 7 KCNA5 variants found in a cohort of PAH patients. Potassium currents were recorded by patch-clamp technique in HEK293 cells transfected with WT or mutant Kv1.5 cDNA. Flow cytometry, western blot and confocal microscopy techniques were used for measuring protein expression and cell apoptosis in HEK293 and human pulmonary artery smooth muscle cells (hPASMC). KCNA5 variants found in PAH patients (namely, p.Arg184Pro and p.Gly384Arg) resulted in a clear loss of potassium channel function as assessed by electrophysiological and molecular modelling analyses. The p.Arg184Pro variant also resulted in a pronounced reduction of Kv1.5 expression. Transfection with p.Arg184Pro or p.Gly384Arg variants decreased apoptosis of hPASMCs compared with the WT, demonstrating that KCNA5 dysfunction in both variants affects cell viability. Thus, in addition to affecting channel activity, both variants were associated with impaired apoptosis, a crucial process linked to the disease. The estimated prevalence of dysfunctional KCNA5 variants in the PAH population analyzed was around 1 %. Our data indicate that some KCNA5 variants found PAH patients have critical consequences for channel function supporting the idea that KCNA5 pathogenic variants may be a causative or contributing factor for PAH., This work was supported by Fundación Contra la Hipertensión Pulmonar (FCHP); Ministerio de Ciencia e Innovación [PID2020-117939RB-I00 to AC, PID2019-104366RB-C21 to TG, PID2019-107363RB-I00 to FPV]; Comunidad de Madrid [B2017/BMD-3727 to AC] and Instituto de Salud Carlos III [PI18/01233, PI21/01593] with funds from the European Union (Fondo Europeo de Desarrollo Regional FEDER); and by an annual grant by the FEDER foundation (Federación Española de Enfermedades Raras)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dietary supplementation with a cocoa–carob blend modulates gut microbiota and prevents intestinal oxidative stress and barrier dysfunction in Zucker diabetic rats

  • García-Díez, Esther
  • López-Oliva, Elvira
  • Pérez-Vizcaíno, Francisco
  • Pérez-Jiménez, Jara
  • Ramos, Sonia
  • Martín, M. Ángeles
We have recently developed a cocoa–carob blend (CCB) rich in polyphenols with antidiabetic properties. In this study, we investigated whether its benefits could be related to gut health and gut microbiota (GM) composition and the likely phenolic metabolites involved. Zucker diabetic fatty rats were fed on a standard or a CCB-rich diet for 12 weeks. Intestinal barrier structure and oxidative and inflammatory biomarkers were analyzed in colonic samples. GM composition and phenolic metabolites were evaluated from feces. The results show that CCB improved mucin and tight-junction proteins and counteracted gut oxidative stress and inflammation by regulating sirtuin-1 and nuclear factor erythroid 2-related factor 2 (Nrf2) levels. CCB also modulated the composition of the GM, showing increases in Akkermansia and Bacteroides and decreases in Ruminococcus genera. Correlation analysis strengthened the associations between these genera and improved pathological variables in diabetic animals. Moreover, 12 phenolic metabolites were identified in CCB feces, being2,3-dihydroxybenzoic and 3,4,5-trihydroxybenzoic acids significantly associated with increased levels of Akkermansia and Oscillospira genera. Our findings support the potential use of CCB to prevent intestinal damage and dysbiosis in T2D, which would help to delay the progression of this pathology., This work was supported by the grants RTI2018-095059-B-I00 and PID2019-107363RB-I00, funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”. E.G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020-AI/BIO-18529)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function

  • Vera-Zambrano, Alba
  • Baena-Nuevo, M.
  • Rinné, Susanne
  • Villegas-Esguevillas, Marta
  • Barreira, Bianca
  • Telli, Gokcen
  • Benito-Bueno, Ángela de
  • Blázquez, J. A.
  • Climent, Belén
  • Pérez-Vizcaíno, Francisco
  • Valenzuela, Carmen
  • Decher, Niels
  • González, Teresa
  • Cogolludo, Angel
KV1.5 channels are key players in the regulation of vascular tone and atrial excitability and their impairment is associated with cardiovascular diseases including pulmonary arterial hypertension (PAH) and atrial fibrillation (AF). Unfortunately, pharmacological strategies to improve KV1.5 channel function are missing. Herein, we aimed to study whether the chaperone sigma-1 receptor (S1R) is able to regulate these channels and represent a new strategy to enhance their function. By using different electrophysiological and molecular techniques in X. laevis oocytes and HEK293 cells, we demonstrate that S1R physically interacts with KV1.5 channels and regulate their expression and function. S1R induced a bimodal regulation of KV1.5 channel expression/activity, increasing it at low concentrations and decreasing it at high concentrations. Of note, S1R agonists (PRE084 and SKF10047) increased, whereas the S1R antagonist BD1047 decreased, KV1.5 expression and activity. Moreover, PRE084 markedly increased KV1.5 currents in pulmonary artery smooth muscle cells and attenuated vasoconstriction and proliferation in pulmonary arteries. We also show that both KV1.5 channels and S1R, at mRNA and protein levels, are clearly downregulated in samples from PAH and AF patients. Moreover, the expression of both genes showed a positive correlation. Finally, the ability of PRE084 to increase KV1.5 function was preserved under sustained hypoxic conditions, as an in vitro PAH model. Our study provides insight into the key role of S1R in modulating the expression and activity of KV1.5 channels and highlights the potential role of this chaperone as a novel pharmacological target for pathological conditions associated with KV1.5 channel dysfunction., This work was supported by Ministerio de Ciencia e Inovación [SAF2016-75021-R; PID2019-104366RB-C21 to C.V. and T.G., PID2020-117939RB-I00 to A.C., PID2019-107363RB-I00 to F.P.V.]; by CIBERCV, by Instituto de Salud Carlos III [CB/11/00222 to C.V.], by CSIC [PIE201820E104; 2019AEP148 to C.V.]. BES-2017-080184 (to A.B.-B.), funded by MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future” funded by Ministerio de Ciencia e Innovación. A.V.-Z., M.B.-N., A.B.-B. and M.V-E. was awarded with predoctoral fellowships: FPI-UAM, CSIC, FPI and FPU predoctoral contracts, respectively. A.V.-Z. was awarded with a Short-term fellowship from the European Molecular Biology Organization (EMBO)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Vitamin D deficiency induces erectile dysfunction: Role of superoxide and Slpi

  • Olivencia, Miguel A.
  • Climent, Belén
  • Barreira, Bianca
  • Morales-Cano, Daniel
  • Sánchez, Ana
  • Fernández, Argentina
  • García-Gómez, Borja
  • Romero-Otero, Javier
  • Rodríguez, Claudia
  • Moreno, Laura
  • Prieto, Dolores
  • Larriba, María Jesús
  • Cogolludo, Angel
  • Angulo, Javier
  • Pérez-Vizcaíno, Francisco
[Background and Purpose] Epidemiological studies suggest a relationship between vitamin D deficiency and erectile dysfunction (ED). We hypothesized that vitamin D deficiency or vitamin D receptor (VDR) knockout causes ED and analysed the underlying molecular mechanisms., [Experimental Approach] Erectile function was assessed in vivo in anaesthetized male mice or rats by evaluating intracavernosal pressure (ICP) and in vitro in male Vdr−/− mice, and rat or human isolated corpora cavernosa (CCs) mounted in a myograph. Bulk RNA-sequencing (RNA-seq) transcriptomic analysis was performed in rat CCs. Vitamin D deficiency was induced in rats fed a vitamin D-free diet for 5 months., [Key Results] CCs from human donors with low plasma vitamin D exhibited reduced nitric oxide (NO)-dependent erectile function. This ED was also reproduced in vitamin D-deficient rats and VDR knockout mice, in vivo and ex vivo, and is associated with penile fibrosis and reduced response to the phosphodiesterase 5 inhibitor (PDE5i) sildenafil. CCs from deficient rats show increased superoxide levels, and their impaired erectile function was restored by superoxide scavengers. Transcriptomic analysis, real-time polymerase chain reaction (RT-PCR) and Western blot showed down-regulated secretory leukocyte protease inhibitor (Slpi). Moreover, recombinant SLPI prevented superoxide-induced ED, while Slpi gene silencing led to reduced erectile function in a superoxide-dependent manner., [Conclusion and Implications] Vitamin D deficiency or VDR knockout reduces erectile function. We suggest that this effect is mediated by increased superoxide levels and down-regulation of SLPI. Vitamin D deficiency might be an aetiological factor for vascular ED and for the therapeutic failure of PDE5i., The work is funded by the Agencia Estatal de Investigación (PID2019-107363RB-I00, PID2019-104867RB-I00, PID2020-117939RB-I00 and PID2022-136729OB-I00, funded by MCIN) and the Instituto de Salud Carlos III—Fondo Europeo de Desarrollo Regional (CIBERES/CB06/06/1084, CIBERONC/CB16/12/00273 and PI22/01302). MJL belongs to the Spanish National Research Council's (CSIC) Cancer Hub. MAO is funded by Universidad Complutense de Madrid—Banco Santander (CT63/19-CT64/19)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Vitamin D as an add-on therapy to phosphodiesterase-5 inhibitor in experimental pulmonary arterial hypertension

  • Adão, Rui
  • Barreira, Bianca
  • Paternoster, Elena
  • Morales-Cano, Daniel
  • Olivencia, Miguel A.
  • Quintana-Villamandos, Begoña
  • Rodríguez Chiaradia, Diego Agustín
  • Cogolludo, Angel
  • Perez-Vizcaino, Francisco
Severe vitamin D (vitD) deficiency is a very common condition in patients with pulmonary arterial hypertension (PAH), and it is a predictor of poor prognosis. There is emerging evidence suggesting a connection between the insufficient response to phosphodiesterase-5 inhibitors (PDE5i) and vitD deficiency in patients with PAH. In the present translational study, vitD deficiency was induced in Wistar rats by exposure to vitD-free diet for 5 wk and followed by Su5416 administration and hypoxia (10%) for 3 wk, a standard experimental model of PAH. Then, rats were randomized to either 1) the PDE5i tadalafil and continuing vitD-free diet or 2) tadalafil plus a single dose of vitD and standard diet for 4 wk. VitD supplementation improved exercise capacity and right ventricular function and decreased systolic right ventricular pressure, right atrial hypertrophy, right ventricular hypertrophy, and pulmonary arterial remodeling. VitD improved the ex vivo endothelium-dependent response to acetylcholine, indicating an improvement in NO bioavailability, which also resulted in an acute ex vivo response to sildenafil. Thus, the restoration of vitD, by rescuing endothelial function and PDE5i effectiveness, significantly improved the histological, hemodynamic, and functional features of rats with PAH. VitD may be especially beneficial for PDE5i-treated patients with PAH. NEW & NOTEWORTHY Severe vitamin D deficiency is very prevalent in patients with pulmonary arterial hypertension. We show that addition of vitamin D to the standard PDE5 inhibitor tadalafil increases its therapeutic efficacy in pulmonary hypertensive rats that were deficient in vitamin D., This study was supported by grants from Ministerio de Economía y Competitividad (PID2019-107363RB-I00 and PID2020-117939RB-I00), Fundación Contra la Hipertensión Pulmonar (FCHP, Empathy study) and Sociedad Española de Neumología y Cirugía Torácica (SEPAR, 1204/2022). R.A. is funded by the EC Horizon 2020 Marie Skłodowska-Curie grant (No. 847635), and acknowledges Fundação para a Ciência e a Technologia (FCT) under the auspices of the project RELAX-2-PAH (2022.08921.PTDC; https://doi.org/10.54499/2022.08921.PTDC). M.A.O. is funded by Universidad Complutense/Banco Santander CT63/19-CT64/19.